DK254488A - Azaindol- og indolizinderivater - Google Patents

Azaindol- og indolizinderivater

Info

Publication number
DK254488A
DK254488A DK254488A DK254488A DK254488A DK 254488 A DK254488 A DK 254488A DK 254488 A DK254488 A DK 254488A DK 254488 A DK254488 A DK 254488A DK 254488 A DK254488 A DK 254488A
Authority
DK
Denmark
Prior art keywords
azaindol
indolizin
derivatives
indolizin derivatives
Prior art date
Application number
DK254488A
Other languages
English (en)
Other versions
DK254488D0 (da
Inventor
Paul Leroy Anderson
Faizulla Gulamhusein Kathawala
Nicholas Andrew Paolella
Sompong Wattanasin
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/945,750 external-priority patent/US4751235A/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of DK254488D0 publication Critical patent/DK254488D0/da
Publication of DK254488A publication Critical patent/DK254488A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK254488A 1986-09-10 1988-05-09 Azaindol- og indolizinderivater DK254488A (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US90589786A 1986-09-10 1986-09-10
US06/945,750 US4751235A (en) 1986-12-23 1986-12-23 Anti-atherosclerotic indolizine derivatives
PCT/EP1987/000511 WO1988001997A2 (en) 1986-09-10 1987-09-09 Azaindole and indolizine derivatives, processes for their production and their use as pharmaceuticals

Publications (2)

Publication Number Publication Date
DK254488D0 DK254488D0 (da) 1988-05-09
DK254488A true DK254488A (da) 1988-06-24

Family

ID=27129444

Family Applications (1)

Application Number Title Priority Date Filing Date
DK254488A DK254488A (da) 1986-09-10 1988-05-09 Azaindol- og indolizinderivater

Country Status (12)

Country Link
EP (1) EP0265640A3 (da)
JP (1) JPH01500834A (da)
KR (1) KR880701719A (da)
AU (1) AU606621B2 (da)
DK (1) DK254488A (da)
FI (1) FI882160A7 (da)
HU (1) HU200769B (da)
IL (1) IL83821A0 (da)
NZ (1) NZ221717A (da)
PL (1) PL267646A1 (da)
PT (1) PT85662B (da)
WO (1) WO1988001997A2 (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0352575A3 (de) * 1988-07-28 1991-08-21 Bayer Ag Substituierte anellierte Pyrrole
IL91941A (en) * 1988-10-13 1994-10-21 Sandoz Ag Preparation of 6-Anoic and 7-Metanoic Fatty Acids and Their Substances and Intermediate Compounds and Acid 7-] 3-) 4-Fluorophenyl (-1-) 1- Methylethyl (a)
JPH04270285A (ja) * 1988-11-14 1992-09-25 Nissan Chem Ind Ltd ピラゾロピリミジン系メバロノラクトン類
US5124453A (en) * 1990-03-02 1992-06-23 E. R. Squibb & Sons, Inc. Process for preparing certain 5,6,7,8-tetrahydroindolizinyl (ethyl or ethynyl)-hydroxy or methoxy-phosphinyl-3-hydroxy-butanoates and derivatives thereof
US5025000A (en) * 1990-03-02 1991-06-18 E. R. Squibb & Sons, Inc. Phosphorus-containing HMG-CoA reductase inhibitor compounds
WO1992019239A1 (en) * 1991-05-01 1992-11-12 University Of New Mexico Treatment of aberrant cellular states with biomodulators
WO1992019240A1 (en) * 1991-05-01 1992-11-12 University Of New Mexico Treatment of aberrant cellular states with biomodulators
FR2687402B1 (fr) * 1992-02-14 1995-06-30 Lipha Nouveaux azaindoles, procedes de preparation et medicaments les contenant.
AU2003281044A1 (en) 2002-07-11 2004-02-02 Takeda Pharmaceutical Company Limited Pyrrolopyridine derivative and use thereof
ES2364340T3 (es) 2004-03-30 2011-08-31 Vertex Pharmaceuticals Incorporated Azaindoles útiles como inhibidores de jak y otras proteína quinasas.
NZ592968A (en) 2006-01-17 2012-08-31 Vertex Pharma Azaindoles substituted with either triazine or pyrimidine useful as inhibitors of janus kinases consisting of JAK1, JAK2, JAK3, and TYK2
WO2008079346A1 (en) 2006-12-21 2008-07-03 Vertex Pharmaceuticals Incorporated 5-cyan0-4- (pyrrolo [2, 3b] pyridine-3-yl) -pyrimidine derivatives useful as protein kinase inhibitors
GEP20207129B (en) 2009-06-17 2020-07-10 Vertex Pharma Inhibitors of influenza viruses replication
RU2013132681A (ru) 2010-12-16 2015-01-27 Вертекс Фармасьютикалз Инкорпорейтед Ингибиторы репликации вирусов гриппа
UA118010C2 (uk) 2011-08-01 2018-11-12 Вертекс Фармасьютікалз Інкорпорейтед Інгібітори реплікації вірусів грипу
PT3068776T (pt) 2013-11-13 2019-08-26 Vertex Pharma Inibidores da replicação de vírus da gripe
HUE038820T2 (hu) 2013-11-13 2018-11-28 Vertex Pharma Eljárás influenzavírusok replikációjának inhibitorai elõállítására
WO2016183120A1 (en) 2015-05-13 2016-11-17 Vertex Pharmaceuticals Incorporated Inhibitors of influenza viruses replication
EP3294717B1 (en) 2015-05-13 2020-07-29 Vertex Pharmaceuticals Inc. Methods of preparing inhibitors of influenza viruses replication

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI61030C (fi) * 1976-02-19 1982-05-10 Sanofi Sa Foerfarande foer framstaellning av terapeutiskt verkande 2-substituerade-1- eller 3-benzoyl-indolizinderivat
JPS5559180A (en) * 1978-10-30 1980-05-02 Sankyo Co Ltd 4-hydroxy-2-pyrone ring compound, its preparation, and remedy for hyperlipemia comprising it as active constituent
US4474971A (en) * 1982-09-29 1984-10-02 Sandoz, Inc. (Tetrahydropyran-2-yl)-aldehydes
HU204253B (en) * 1982-11-22 1991-12-30 Sandoz Ag Process for producing mevalonolactone analogues and derivatives and pharmaceutical compositions containing them
EP0117228B1 (en) * 1983-01-24 1986-11-05 Sandoz Ag Analogs of mevalonolactone and derivatives thereof, processes for their production, pharmaceutical compositions containing them and their use as pharmaceuticals
US4571428A (en) * 1983-07-08 1986-02-18 Sandoz, Inc. 6-Substituted-4-hydroxy-tetrahydropyran-2-ones
HU198711B (en) * 1984-06-22 1989-11-28 Sandoz Ag Process for producing mevalolacton, derivatives and pyrazol analogues and pharmaceutical composition containing them
US4677211A (en) * 1984-06-29 1987-06-30 Sandoz Pharmaceuticals Corp. Preparation of lactones
US4668794A (en) * 1985-05-22 1987-05-26 Sandoz Pharm. Corp. Intermediate imidazole acrolein analogs

Also Published As

Publication number Publication date
WO1988001997A3 (en) 1988-04-07
PT85662B (pt) 1990-06-29
HU200769B (en) 1990-08-28
WO1988001997A2 (en) 1988-03-24
FI882160A0 (fi) 1988-05-09
AU8022187A (en) 1988-04-07
KR880701719A (ko) 1988-11-04
NZ221717A (en) 1990-08-28
IL83821A0 (en) 1988-02-29
EP0265640A2 (en) 1988-05-04
FI882160A7 (fi) 1988-05-09
AU606621B2 (en) 1991-02-14
PT85662A (en) 1987-10-01
JPH01500834A (ja) 1989-03-23
DK254488D0 (da) 1988-05-09
EP0265640A3 (en) 1988-05-18
PL267646A1 (en) 1988-07-21
HUT46914A (en) 1988-12-28

Similar Documents

Publication Publication Date Title
IT1205010B (it) Tetraidronaftalin-derivati e indan-derivati
DK366787D0 (da) Tetrahydronaphthalen- og indanderivater
DK263587A (da) Imidazoquinolinyletherderivater
DK82087A (da) Pyrocatecholderivater
ATA312487A (de) Tetrahydrocarbazolonderivate
DK69887A (da) Dichloranilinderivater
DK254488D0 (da) Azaindol- og indolizinderivater
DK693587D0 (da) Alkansulfonanilidderivater
DK641587A (da) Benzofuran- og benzopyranderivater
DK139286A (da) Inden- og naphthalenderivater
DK81888D0 (da) Dibenzoxepinderivater
DK691287D0 (da) 5-floururacilderivater
DE3680771D1 (de) Isoxazolopyridophenoxazin- und isothiazolopyridophenoxazinderivate.
DK444687D0 (da) Alfa-substituerede ketonitron-derivater
DE3680775D1 (de) Isoxazolopyridobenzoxazin- und isothiazolopyridobenzoxazinderivate.
DK440687A (da) Bicyclooctanderivater
DK619187A (da) Isoindolderivater
DK229887D0 (da) Alkenamidderivater
DK435087A (da) Isoprenderivater
DK440787A (da) Bicyclooctanderivater
DK289887A (da) Anvendelse af avaron- og avarolderivater
DK289987A (da) Anvendelse af avaron- og avarolderivater
DK691087D0 (da) Dioxazocinderivater
FI905165A7 (fi) Dibentsodioksatsesiini-ja dibentsodioksa-atsasykloundekiini-johdannaisia
BR8601118A (pt) Imantador e desimantador

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment